Crossmark

Translational studies support a role for serotonin 2B receptor (HTR2B) gene in aggression-related cannabis response

Crossref DOI link: https://doi.org/10.1038/s41380-018-0077-6

Published Online: 2018-06-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Montalvo-Ortiz, Janitza L. https://orcid.org/0000-0002-7657-8365
Zhou, Hang https://orcid.org/0000-0002-7694-6391
D’Andrea, Ivana

Maroteaux, Luc https://orcid.org/0000-0002-9499-8603
Lori, Adriana

Smith, Alicia https://orcid.org/0000-0002-8537-5156
Ressler, Kerry J.

Nuñez, Yaira Z.

Farrer, Lindsay A.

Zhao, Hongyu

Kranzler, Henry R. https://orcid.org/0000-0002-1018-0450
Gelernter, Joel https://orcid.org/0000-0002-4067-1859
License Information

Text and Data Mining valid from 2018-06-06
More Information

Article History

Received: 19 December 2017

Revised: 17 April 2018

Accepted: 23 April 2018

First Online: 6 June 2018

Compliance with ethical standards

:

: Although unrelated to the current study, HRK has been a consultant, advisory board member, or CME speaker for Indivior and Lundbeck. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which in the last 3 years was supported by Abbvie, Alkermes, Amygdala Neurosciences, Arbor, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, and Pfizer. The remaining authors declare that they have no conflict of interest.